196 related articles for article (PubMed ID: 36745179)
1. Prenatal Opioid Exposure and Neurodevelopmental Outcomes.
Lee JJ; Saraiya N; Kuzniewicz MW
J Neurosurg Anesthesiol; 2023 Jan; 35(1):142-146. PubMed ID: 36745179
[TBL] [Abstract][Full Text] [Related]
2. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
[TBL] [Abstract][Full Text] [Related]
3. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
Elife; 2021 Mar; 10():. PubMed ID: 33724184
[TBL] [Abstract][Full Text] [Related]
4. Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.
Bakhireva LN; Holbrook BD; Shrestha S; Leyva Y; Ashley M; Cano S; Lowe J; Stephen JM; Leeman L
Early Hum Dev; 2019 Jan; 128():69-76. PubMed ID: 30554024
[TBL] [Abstract][Full Text] [Related]
5. Prenatal Risk Factors and Perinatal and Postnatal Outcomes Associated With Maternal Opioid Exposure in an Urban, Low-Income, Multiethnic US Population.
Azuine RE; Ji Y; Chang HY; Kim Y; Ji H; DiBari J; Hong X; Wang G; Singh GK; Pearson C; Zuckerman B; Surkan PJ; Wang X
JAMA Netw Open; 2019 Jun; 2(6):e196405. PubMed ID: 31251378
[TBL] [Abstract][Full Text] [Related]
6. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure.
Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM
Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326
[TBL] [Abstract][Full Text] [Related]
7. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
8. Risk of neonatal drug withdrawal after intrauterine co-exposure to opioids and psychotropic medications: cohort study.
Huybrechts KF; Bateman BT; Desai RJ; Hernandez-Diaz S; Rough K; Mogun H; Kerzner LS; Davis JM; Stover M; Bartels D; Cottral J; Patorno E
BMJ; 2017 Aug; 358():j3326. PubMed ID: 28768628
[No Abstract] [Full Text] [Related]
9. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
10. Effects of polysubstance exposure on neonatal outcomes for infants with intrauterine opioid exposure.
McDaniel CE; Test M; Deodhar P; Jennings R; Bove J; Carlin K
J Perinatol; 2020 Oct; 40(10):1489-1496. PubMed ID: 32641774
[TBL] [Abstract][Full Text] [Related]
11. A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Sujan A; Cleary E; Douglas E; Aujla R; Boyars L; Smith C; Guille C
Fam Pract; 2022 Mar; 39(2):311-315. PubMed ID: 34537839
[TBL] [Abstract][Full Text] [Related]
12. Opioids affect the fetal brain: reframing the detoxification debate.
Caritis SN; Panigrahy A
Am J Obstet Gynecol; 2019 Dec; 221(6):602-608. PubMed ID: 31323217
[TBL] [Abstract][Full Text] [Related]
13. Impact of
Bailey BA; Shah DS; Boynewicz KL; Justice NA; Wood DL
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):9383-9390. PubMed ID: 35109759
[TBL] [Abstract][Full Text] [Related]
14. Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes.
Jansson LM; Di Pietro JA; Elko A; Williams EL; Milio L; Velez M
Drug Alcohol Depend; 2012 May; 122(3):213-9. PubMed ID: 22041255
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome.
Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A
J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916
[TBL] [Abstract][Full Text] [Related]
16. Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome.
Bhatt-Mehta V; Richards J; Sturza J; Schumacher RE
J Addict Med; 2019; 13(3):227-234. PubMed ID: 30489344
[TBL] [Abstract][Full Text] [Related]
17. Trajectories of Prescription Opioid Utilization During Pregnancy Among Prepregnancy Chronic Users and Risk of Neonatal Opioid Withdrawal Syndrome.
Straub L; Huybrechts KF; Hernández-Díaz S; Zhu Y; Vine S; Desai RJ; Gray KJ; Bateman BT
Am J Epidemiol; 2022 Jan; 191(1):208-219. PubMed ID: 34643225
[TBL] [Abstract][Full Text] [Related]
18. Ophthalmic outcomes in children exposed to opioid maintenance treatment in utero: A systematic review and meta-analysis.
Hemmati Z; Conti AA; Baldacchino A
Neurosci Biobehav Rev; 2022 May; 136():104601. PubMed ID: 35263646
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of opioid use in pregnancy.
Cook JL
Best Pract Res Clin Obstet Gynaecol; 2022 Dec; 85(Pt B):12-17. PubMed ID: 36045026
[TBL] [Abstract][Full Text] [Related]
20. Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.
Liu AJ; Jones MP; Murray H; Cook CM; Nanan R
Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):253-8. PubMed ID: 20618243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
